Aldeyra Therapeutics (ALDX)CEO bought ~$418K

~$418K

Approx. value · 250K sh @ $1.67

1.72M

Holds after · shares reported

Traded

Jun 3, 2026

Filed

Jun 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 20, 2026, Martin J. Joyce, a member of the Board of Directors of Aldeyra Therapeutics, Inc. (“Aldeyra”), notified Aldeyra of his decision to not stand for re-election at the upcoming 2026 annual meeting of stockholders (the “2026 Annual Meeting”).”
2. Jun 3, 2026 · this disclosureInsider · 6 days before an 8-KCEO purchased ~$418K of ALDX shares in the open market

What came next

1. Jun 9, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote (and 1 more item)“On June 9, 2026, following Aldeyra Therapeutics, Inc.’s (the “Company”) 2026 annual meeting of stockholders (the “2026 Annual Meeting”), and based upon the recommendation of the Nominating/Corporate Governance Committee of the Board of Directors (the “Board”), the Board appointed Darlene Deptula-Hicks as a Class III director, with her initial term expiring at the Company’s 2029 annual meeting of stockholders.”
2. Jul 28, 2026Company filing · Form 8-K · Material agreementSigned an important agreement

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aldeyra Therapeutics

OQRO holds no insider, Congress, fund or contract record for Aldeyra Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALDX page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Aldeyra Therapeutics

• SEC Form 13F-HRMay 29, 2026
• SEC Form 4Mar 20, 2026
• SEC Form 4Mar 19, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 4Aug 15, 2025

Everything OQRO holds on this company is on its ALDX page.